Does a $5M to $10M ARR life sciences company need a fractional CRO in 2027?

Direct Answer
Life sciences companies at this ARR range face a unique challenge: your revenue cycle is long (often 6–18 months), your buyer is scientific and risk-averse, and your go-to-market motion is heavily regulated. A fractional CRO can bring senior-level strategy—pipeline generation, sales process design, channel partnerships—without the overhead of a full-time executive. However, if your core problem is simply "we need more sales reps closing deals," a fractional CRO won't fix that; you likely need a VP of Sales or a few AEs. The fractional model works best when you have a strategic bottleneck—e.g., no repeatable sales process, no clear ICP, or a founder who's overwhelmed wearing the CRO hat.
Why Life Sciences Is Different at $5M–$10M ARR
Life sciences companies—biotech, medtech, diagnostics, pharma services—operate on a fundamentally different revenue cadence than B2B SaaS. Your buyers are PhDs, MDs, or procurement teams who demand clinical evidence, regulatory clarity, and long-term reliability. A typical sales cycle can span 6 to 18 months, with multiple technical validations and compliance reviews. At $5M–$10M ARR, you've likely proven product-market fit but haven't yet built a repeatable sales machine. The founder often handles the first few enterprise deals, but scaling beyond that requires a systematic approach to pipeline generation, deal qualification, and closing—all while navigating FDA, HIPAA, or EU MDR regulations.
A fractional CRO who has lived through these cycles can help you design a sales process that accounts for regulatory gatekeepers, KOL (key opinion leader) influence, and long procurement timelines. They can also help you decide whether to build a direct sales team, use channel partners (e.g., distributors, CROs), or both. Without this experience, you risk wasting months on generic SaaS playbooks that don't fit your market.
When a Fractional CRO Is a Bad Idea
Not every $5M–$10M life sciences company needs a fractional CRO. Here are three scenarios where it's likely a mistake:
- You have no pipeline at all. If your revenue is flat because you have zero leads, a fractional CRO won't generate them. You need a demand generation specialist or a business development rep first.
- Your founder is the only closer. If the CEO owns every deal and refuses to delegate, a fractional CRO will be sidelined. The CRO can coach, but they can't close deals the founder won't hand over.
- You're burning cash and can't afford $10K–$20K/month. Fractional CROs are not cheap. If your runway is under 12 months, prioritize a commission-only sales rep or a part-time VP of Sales at a lower cost.
How to Evaluate a Fractional CRO for Life Sciences
When interviewing candidates, ask these specific questions:
- "Walk me through a deal you closed in a regulated industry." Listen for specifics about compliance steps, technical validations, and buyer committee structures.
- "How do you handle a 12-month sales cycle with multiple stakeholders?" Good answers include stage-gating, champion development, and executive engagement plans.
- "What tools do you use for pipeline management?" Expect mentions of Salesforce, HubSpot, Clari, or Gong—but no quantified claims about their impact.
- "How do you work with a founder who's still selling?" A strong fractional CRO will have a clear delegation plan, not a "just trust me" attitude.
The Cost-Benefit Math
Let's be honest about the numbers. A full-time CRO at a life sciences company in 2027 will cost you $250,000–$400,000 in total compensation (base salary, bonus, equity, benefits). A fractional CRO at 2–3 days per week will cost $8,000–$15,000 per month (or $96,000–$180,000 annually) plus equity. The fractional option saves you $70,000–$220,000 per year in cash, but you get less time and focus. The trade-off is clear: if you need deep immersion in your team and culture, go full-time. If you need strategic guidance and process design without the overhead, go fractional.
What to Expect in the First 90 Days
A good fractional CRO will spend the first month auditing your current revenue engine: pipeline data, sales process, team skills, and market positioning. They'll produce a 30-60-90 day plan with specific, measurable outcomes. Month two focuses on execution: implementing a sales methodology, coaching reps, and building a pipeline review cadence. Month three is about sustainability: documenting processes, training your team to run without them, and setting up metrics you can track.
You should expect weekly 1:1s with the founder, bi-weekly pipeline reviews, and monthly board-level updates. The CRO should not be a black box—they should be transparent about what's working, what's not, and whether you need to adjust scope.
FAQ
What's the difference between a fractional CRO and a sales consultant? A fractional CRO operates as a part-time executive—they attend leadership meetings, own revenue metrics, and manage the sales team. A sales consultant typically gives advice without authority. Fractional CROs have decision-making power; consultants don't.
Can a fractional CRO work remotely for a life sciences company? Yes, but with caveats. Life sciences often requires in-person visits to labs, hospitals, or conferences. A remote fractional CRO can handle strategy, pipeline management, and team coaching, but you'll need someone who can travel quarterly for key meetings or events. Many fractional CROs are open to hybrid arrangements.
How do I know if the fractional CRO is actually working? Set clear KPIs upfront: pipeline coverage ratio (e.g., 3x–5x target), deal velocity (average days from stage to close), and win rate. Review these monthly. If the CRO can't show progress after 90 days, it's time to reassess.
Will a fractional CRO replace my VP of Sales? Not necessarily. If you have a VP of Sales who's good at execution but weak at strategy, a fractional CRO can coach them and handle the strategic layer. If your VP of Sales is underperforming, the fractional CRO may recommend a replacement.
What equity should I offer a fractional CRO? Typical ranges are 0.5%–2% fully vested over 2–3 years, with a one-year cliff. The exact number depends on the CRO's experience, the scope of work, and whether you're offering cash at the high or low end of the monthly range. Never offer equity without vesting and a cliff.
How do I find a fractional CRO with life sciences experience?
Sources
- Pavilion – Community for revenue leaders
- RevOps Co-op – Revenue operations community
- Harvard Business Review – Sales process design
- First Round Review – Startup leadership advice
- SaaStr – SaaS revenue and scaling
- LinkedIn – Professional network for vetting candidates
People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost